Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.64 USD | +1.47% | -8.84% | -26.06% |
May. 15 | Sector Update: Health Care Stocks Advance Late Wednesday Afternoon | MT |
May. 15 | T2 Biosystems Shares Rise After CRG Servicing Ups Stake | MT |
Financials (USD)
Sales 2024 * | 10.5M | Sales 2025 * | 23.1M | Capitalization | 79.19M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | -47M | EV / Sales 2024 * | 7.54 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.43 x |
P/E ratio 2024 * |
-1.26
x | P/E ratio 2025 * |
-3.31
x | Employees | 113 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 28.09% |
Latest transcript on T2 Biosystems, Inc.
1 day | +1.47% | ||
1 week | -8.84% | ||
Current month | -9.73% | ||
1 month | +24.73% | ||
3 months | -5.69% | ||
6 months | +24.06% | ||
Current year | -26.06% |
Managers | Title | Age | Since |
---|---|---|---|
John Sperzel
CEO | Chief Executive Officer | 60 | 20-01-07 |
John Sprague
DFI | Director of Finance/CFO | 65 | 18-01-29 |
Roger Smith
CTO | Chief Tech/Sci/R&D Officer | 59 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Elsbree
BRD | Director/Board Member | 76 | 14-06-30 |
Seymour Liebman
BRD | Director/Board Member | 74 | 16-09-20 |
Robin Toft
BRD | Director/Board Member | 63 | 20-06-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 4.64 | +2.20% | 172,779 |
24-06-04 | 4.54 | -5.02% | 91,672 |
24-06-03 | 4.78 | -7.00% | 95,691 |
24-05-31 | 5.14 | +1.58% | 84,601 |
24-05-30 | 5.06 | -0.59% | 54,217 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.06% | 79.19M | |
+8.38% | 220B | |
+15.78% | 198B | |
+31.27% | 112B | |
+4.49% | 66.17B | |
+14.19% | 52.47B | |
+4.70% | 50.77B | |
-3.93% | 38.97B | |
-0.47% | 35.13B | |
+23.96% | 31.32B |
- Stock Market
- Equities
- TTOO Stock